During the past decade, Jersey Shore Cancer Center at Jersey Shore University Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" #1 sponsor was "Gynecologic Oncology Group" with 2 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Fox Chase Cancer Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Rutgers Cancer Institute of New Jersey" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials), "Cancer Survivor" (1 trials) and "Cognitive/Functional Effects" (1 trials). Many other conditions were trialed in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" in a lesser frequency.

Most popular intervention types in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (3 trials), "carboplatin" (2 trials), "imatinib mesylate" (2 trials), "paclitaxel" (2 trials) and "atrasentan hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are 5 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jersey Shore Cancer Center at Jersey Shore University Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Jersey Shore Cancer Center at Jersey Shore University Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jersey Shore Cancer Center at Jersey Shore University Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".